Torii Pharmaceutical Co., Ltd. (TYO:4551)
4,395.00
-55.00 (-1.24%)
Mar 10, 2025, 3:30 PM JST
Torii Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 3,319 | 5,004 | 9,203 | 4,012 | 3,717 | Upgrade
|
Short-Term Investments | 39,979 | 38,999 | 49,706 | 61,560 | 66,387 | Upgrade
|
Cash & Short-Term Investments | 43,298 | 44,003 | 58,909 | 65,572 | 70,104 | Upgrade
|
Cash Growth | -1.60% | -25.30% | -10.16% | -6.46% | -8.62% | Upgrade
|
Accounts Receivable | 31,068 | 28,502 | 22,865 | 22,010 | 18,955 | Upgrade
|
Receivables | 31,068 | 28,502 | 22,865 | 22,010 | 18,955 | Upgrade
|
Inventory | 14,217 | 10,742 | 8,969 | 8,763 | 7,151 | Upgrade
|
Prepaid Expenses | 1,225 | 663 | 307 | 152 | 145 | Upgrade
|
Other Current Assets | 4,832 | 4,238 | 553 | 795 | 387 | Upgrade
|
Total Current Assets | 94,640 | 88,148 | 91,603 | 97,292 | 96,742 | Upgrade
|
Property, Plant & Equipment | 2,451 | 2,095 | 2,282 | 2,078 | 1,777 | Upgrade
|
Long-Term Investments | 42,444 | 41,895 | 38,636 | 30,286 | 26,477 | Upgrade
|
Other Intangible Assets | 321 | 429 | 517 | 512 | 442 | Upgrade
|
Long-Term Deferred Tax Assets | 805 | 863 | 650 | 641 | 587 | Upgrade
|
Other Long-Term Assets | 3 | 2 | 1 | 1 | 1 | Upgrade
|
Total Assets | 140,664 | 133,432 | 133,689 | 130,810 | 126,026 | Upgrade
|
Accounts Payable | 10,448 | 6,981 | 6,584 | 5,793 | 5,143 | Upgrade
|
Accrued Expenses | 967 | 931 | 753 | 812 | 689 | Upgrade
|
Current Portion of Leases | 148 | 222 | 283 | 211 | 85 | Upgrade
|
Current Income Taxes Payable | 5,979 | 3,708 | 4,920 | 4,863 | 3,127 | Upgrade
|
Other Current Liabilities | 611 | 662 | 681 | 693 | 417 | Upgrade
|
Total Current Liabilities | 18,153 | 12,504 | 13,221 | 12,372 | 9,461 | Upgrade
|
Long-Term Leases | 281 | 22 | 241 | 275 | 209 | Upgrade
|
Other Long-Term Liabilities | 303 | 295 | 296 | 312 | 318 | Upgrade
|
Total Liabilities | 19,131 | 13,299 | 14,465 | 13,796 | 10,936 | Upgrade
|
Common Stock | 5,190 | 5,190 | 5,190 | 5,190 | 5,190 | Upgrade
|
Additional Paid-In Capital | 6,473 | 6,460 | 6,453 | 6,445 | 6,437 | Upgrade
|
Retained Earnings | 110,813 | 109,425 | 108,846 | 106,250 | 104,224 | Upgrade
|
Treasury Stock | -1,358 | -1,369 | -1,381 | -1,393 | -1,407 | Upgrade
|
Comprehensive Income & Other | 415 | 427 | 116 | 522 | 646 | Upgrade
|
Shareholders' Equity | 121,533 | 120,133 | 119,224 | 117,014 | 115,090 | Upgrade
|
Total Liabilities & Equity | 140,664 | 133,432 | 133,689 | 130,810 | 126,026 | Upgrade
|
Total Debt | 429 | 244 | 524 | 486 | 294 | Upgrade
|
Net Cash (Debt) | 42,869 | 43,759 | 58,385 | 65,086 | 69,810 | Upgrade
|
Net Cash Growth | -2.03% | -25.05% | -10.30% | -6.77% | -8.56% | Upgrade
|
Net Cash Per Share | 1525.08 | 1557.09 | 2078.05 | 2317.05 | 2486.00 | Upgrade
|
Filing Date Shares Outstanding | 28.11 | 28.11 | 28.1 | 28.09 | 28.08 | Upgrade
|
Total Common Shares Outstanding | 28.11 | 28.11 | 28.1 | 28.09 | 28.08 | Upgrade
|
Working Capital | 76,487 | 75,644 | 78,382 | 84,920 | 87,281 | Upgrade
|
Book Value Per Share | 4323.28 | 4274.28 | 4243.45 | 4165.24 | 4098.35 | Upgrade
|
Tangible Book Value | 121,212 | 119,704 | 118,707 | 116,502 | 114,648 | Upgrade
|
Tangible Book Value Per Share | 4311.86 | 4259.02 | 4225.05 | 4147.01 | 4082.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.